keyword
https://read.qxmd.com/read/31464291/-pharmacoeconomic-analysis-of-the-neuroprotective-medicines-in-the-treatment-of-ischemic-stroke
#21
JOURNAL ARTICLE
R I Yagudina, A Yu Kulikov, V A Krylov, E Yu Solovieva, A I Fedin
AIM: To perform a pharmacoeconomic analysis of the most frequently prescribed neuroprotective medicines for treating patients with mild ischemic stroke in the acute and early rehabilitation periods in the Russian Federation. MATERIAL AND METHODS: Three medical technologies were compared: ethylmethylhydroxypyridine succinate (mexidol), inosine + nicotinamide + riboflavin + succinic acid (cytoflavin) and a deproteinized hemoderivate of the blood of calves (actovegin)...
2019: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/30872059/biotechnological-wound-dressings-based-on-bacterial-cellulose-and-degradable-copolymer-p-3hb-4hb
#22
JOURNAL ARTICLE
T G Volova, A A Shumilova, E D Nikolaeva, A K Kirichenko, E I Shishatskaya
Hybrid wound dressings have been constructed using two biomaterials: bacterial cellulose (BC) and copolymer of 3-hydroxybutyric and 4-hydroxybutyric acids [P(3HB/4HB)] - a biodegradable polymer of microbial origin. Some of the experimental membranes were loaded with drugs promoting wound healing and epidermal cells differentiated from multipotent adipose-derived mesenchymal stem cells. A study has been carried out to investigate the structure and physical/mechanical properties of the membranes. The in vitro study showed that the most effective scaffolds for growing fibroblasts were composite BC/P(3HB/4HB) films loaded with actovegin...
June 15, 2019: International Journal of Biological Macromolecules
https://read.qxmd.com/read/30701835/multimodal-approach-to-treatment-of-neurological-complications-of-chronic-brain-ischemia
#23
JOURNAL ARTICLE
M M Tanashyan, A A Shabalina, O V Lagoda, A A Raskurazhev, R N Konovalov
AIM: The study of Actovegin effectin clinical presentations and hemorheological characteristics in patients with chronic cerebrovascular pathology (CCVP) and mild cognitive impairment. MATERIALS AND METHODS: The study group included 47 patients (25 male and 22 female), aged 61-75 years (mean age 63.8±5.4) with CCVP who were treated with Actovegin. The control group comprised 28 patients matched by gender and age, without associated cerebrovascular pathology. All patients along with thorough neurological examination underwent laboratory analyses (platelet and erythrocyte rheology), neurovisualization studies (functional magnetic resonance imaging of the brain)...
December 30, 2018: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/30678228/prevention-and-treatment-of-chemotherapy-and-radiotherapy-induced-oral-mucositis
#24
JOURNAL ARTICLE
Goda Daugėlaitė, Kristė Užkuraitytė, Eglė Jagelavičienė, Aleksas Filipauskas
Background and o bjectives : Oral mucositis is one of the main adverse events of cancer treatment with chemotherapy or radiation therapy. It presents as erythema, atrophy or/and ulceration of oral mucosa. It occurs in almost all patients, who receive radiation therapy of the head and neck area and from 20% to 80% of patients who receive chemotherapy. There are few clinical trials in the literature proving any kind of treatment or prevention methods to be effective. Therefore, the aim of this study is to perform systematic review of literature and examine the most effective treatment and prevention methods for chemotherapy or/and radiotherapy induced oral mucositis...
January 22, 2019: Medicina
https://read.qxmd.com/read/30346435/-methods-of-augmentation-of-antidepressant-therapy-on-the-model-of-complex-therapy-with-the-inclusion-of-actovegin-in-gerontopsychiatric-hospital
#25
JOURNAL ARTICLE
T P Safarova, O B Yakovleva, V S Sheshenin, S I Gavrilova
AIM: Increasing the effectiveness of treatment of elderly depressed patients in the conditions of the gerontopsychiatric hospital by augmentation of actovegin to antidepressants of new generations (fluvoxamine, venlafaxine or agomelatine). MATERIAL AND METHODS: The efficacy of the therapy was compared in two groups of 21 patients aged 60 to 79 years with mild to moderate depression in ICD-10 receiving 8-week antidepressant mono- or combined therapy with actovegin...
2018: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/30186981/influence-of-pharmacological-preconditioning-on-the-results-of-lifting-operations-efficiency
#26
JOURNAL ARTICLE
N E Manturova, V A Stupin, G O Smirnova, E V Silina
The main aim of the study is to determine the effectiveness and safety of lifting operations in women with varying degrees of involuntary changes of facial skin, in particular when applying pharmacological conditioning, with the objectification of the role of the latter. Materials and methods: A research and surgical treatment were conducted to eliminate involutional changes of various degrees in the facial skin of 461 women aged 35-75 years. Surface lifting was performed in 20.2% of patients, SMAS-lifting - 49...
August 2018: Heliyon
https://read.qxmd.com/read/29688190/-present-day-possibilities-of-non-invasive-control-over-microcirculation-and-metabolism-in-man
#27
RANDOMIZED CONTROLLED TRIAL
A A Fedorovich, A G Bagdasarian, I G Uchkin, G N Soboleva, S A Boĭtsov
The main function of the microcirculatory bed consists in maintaining tissue homeostasis at an optimal level irrespective of the effect of various external and internal factors. Of all types of metabolism (diffusive, filtration-reabsorption and vesicular), directly dependent on the haemodynamic parameters is filtration-reabsorption metabolism which provides exchange of water, low-molecular-weight and water-soluble substances at the opposite to the heart «pole» of the cardiovascular system. The present study was aimed at testing a hypothesis that activation of metabolic processes in man would be accompanied by alterations in haemodynamic parameters which may be registered by means of modern non-invasive methods of examination, i...
2018: Angiology and Vascular Surgery
https://read.qxmd.com/read/29337720/update-on-the-role-of-actovegin-in-musculoskeletal-medicine-a-review-of-the-past-10-years
#28
JOURNAL ARTICLE
James Brock, David Golding, Paul M Smith, Len Nokes, Alvin Kwan, Paul Y F Lee
BACKGROUND: Actovegin is a biological drug with a controversial history of use in the treatment of sports injuries during the past 60 years. Particular concerns have been raised about its ergogenic potential to enhance performance, but some of these have been based on little more than anecdote. OBJECTIVES: In this article, we review the most recent scientific evidence to determine the clinical efficacy, safety profile, and legal status of Actovegin. METHODS: We considered all studies directly commenting on experience with Actovegin use as the primary intervention within the past 10 years...
January 15, 2018: Clinical Journal of Sport Medicine
https://read.qxmd.com/read/29074122/erratum-to-dan-ziegler-sally-edmundson-irina-gurieva-boris-mankovsky-nikolaos-papanas-igor-strokov-predictors-of-response-to-treatment-with-actovegin-for-6-months-in-patients-with-type-2-diabetes-and-symptomatic-polyneuropathy-j-diabetes-complications-2017
#29
https://read.qxmd.com/read/28914850/-correction-of-small-bowel-function-as-a-new-direction-for-treating-patients-with-metabolic-syndrome
#30
JOURNAL ARTICLE
Ya M Vakhrushev, M V Lyapina
AIM: To provide a rationale for and to evaluate the therapeutic efficiency of the combined use of pancreatic enzymes and actovegin in the combination therapy of patients with metabolic syndrome (MS) on the basis of comprehensive clinical and functional studies of the small bowel (SB). SUBJECTS AND METHODS: In the course of treatment, 120 patients with MS (verified using the diagnostic criteria elaborated by the All-Russian Research Society of Cardiology (2009)) underwent a comprehensive study of SB function: an isolated study of resorptive processes; evaluation of parietal and cavitary digestion, motor-evacuation function...
2017: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/28895623/comprehensive-analytics-of-actovegin%C3%A2-and-its-effect-on-muscle-cells
#31
JOURNAL ARTICLE
Franz-Xaver Reichl, Lesca Miriam Holdt, Daniel Teupser, Gregor Schütze, Alan J Metcalfe, Reinhard Hickel, Christof Högg, Wilhelm Bloch
The ingredients of Actovegin® were analyzed and its effects on the muscle cell proliferation were investigated. C2C12 myoblasts were cultured in medium. Actovegin® was added in five different concentrations (1, 5, 25, 125, and 250 µg) to the differentiation medium. The formations of proliferation factor Ki67 and myosin heavy chains were measured by immunofluorescence. The first primary antibody was anti-Ki67 and anti-Mf20. Cells were washed and treated with the second fluorochrome. Thirty-one Actovegin® ingredients were found to contain significantly higher concentrations and twenty-nine ingredients were found to contain significantly lower concentrations, compared to the mean ranges as described in the literature for the normal physiological concentrations in human adult serum/plasma...
October 2017: International Journal of Sports Medicine
https://read.qxmd.com/read/28786085/pharmacotherapy-for-vascular-cognitive-impairment
#32
REVIEW
Muhammad U Farooq, Jiangyong Min, Christopher Goshgarian, Philip B Gorelick
Vascular cognitive impairment (VCI) is the second most common type of dementia after Alzheimer's disease (AD). Stroke and cardiovascular risk factors have been linked to both AD and VCI and potentially can affect cognitive function in mid and later life. Various pharmacological agents, including donepezil, galantamine, and memantine, approved for the treatment of AD have shown modest cognitive benefits in patients with vascular dementia (VaD). However, their functional and global benefits have been inconsistent...
September 2017: CNS Drugs
https://read.qxmd.com/read/28574384/-evaluation-of-quality-indicators-of-life-as-a-criterion-of-the-efficiency-of-treatment-for-liquidators-of-the-accident-at-chernobyl-aerosphorus-patients-with-hypertension-disease-comorbid-with-gastroesophageal-reflux-disease
#33
JOURNAL ARTICLE
V Synelnik, A Oparin
In order to assess the quality of life of liquidators of the accident at the Chernobyl nuclear power plant (CHPP) of patients with hypertensive comorbid disease with gastroesophageal reflux disease, 52 patients aged 46 to 71 years (mean age 57.5±0, 8 years old) who were on inpatient treatment in the therapeutic department of the Regional Clinical Specialized Dispensary for Radiation Protection of the Population of Kharkov from January 2016 to December 2016. The men among the examined were 44 (84.6%), women - 8 (15...
April 2017: Georgian Medical News
https://read.qxmd.com/read/28574034/-effect-of-actovegin-and-solcoseryl-on-microcirculation-in-experimental-critical-lower-limb-ischaemia
#34
JOURNAL ARTICLE
A Iu Orlova, B S Sukovatykh, E B Artiushkova, M Iu Gordov
The authors examined the effect of actovegin and solcoseryl on microcirculation parameters in treatment of experimental critical lower limb ischaemia. The study included a total of 130 male Wistar albino rats divided into four groups: intact, control, first and second study groups. The intact group consisted of 10 animals used for assessment of the normal indices of microcirculation, with the remaining three groups comprising 40 rats each. All animals, except the intact ones, were subjected to modelled critical ischaemia of a hind limb...
2017: Angiology and Vascular Surgery
https://read.qxmd.com/read/28438471/predictors-of-response-to-treatment-with-actovegin-for-6-months-in-patients-with-type-2-diabetes-and-symptomatic-polyneuropathy
#35
RANDOMIZED CONTROLLED TRIAL
Dan Ziegler, Sally Edmundson, Irina Gurieva, Boris Mankovsky, Nikolaos Papanas, Igor Strokov
AIMS: To evaluate two definitions of response and the predictive value of baseline covariates for response to actovegin treatment in type 2 diabetic patients with symptomatic diabetic sensorimotor polyneuropathy (DSPN). METHODS: Response to 6-months treatment with actovegin or placebo was defined as a clinically meaningful decline from baseline to 6months in (1) both Neuropathy Impairment Score of Lower Limbs (NIS-LL) ≥2 points and Total Symptom Score (TSS) >50% and (2) NIS-LL ≥2 points only...
July 2017: Journal of Diabetes and its Complications
https://read.qxmd.com/read/28432265/artemida-trial-a-randomized-trial-of-efficacy-12-months-international-double-blind-actovegin-a-randomized-controlled-trial-to-assess-the-efficacy-of-actovegin-in-poststroke-cognitive-impairment
#36
RANDOMIZED CONTROLLED TRIAL
Alla Guekht, Ingmar Skoog, Sally Edmundson, Vladimir Zakharov, Amos D Korczyn
BACKGROUND AND PURPOSE: Poststroke cognitive impairment is a debilitating consequence of stroke. The aim of this study was to assess whether Actovegin confers cognitive benefit in patients who have had an ischemic stroke. METHODS: This was a 12-month, parallel-group, randomized, multicenter, double-blind, placebo-controlled study. Eligible patients were ≥60 years of age with a Montreal Cognitive Assessment test score of ≤25 points. Patients were randomized into 2 groups within 1 week of acute supratentorial ischemic stroke in a 1:1 ratio: Actovegin (a deproteinized hemoderivative of calf blood, 2000 mg/d for ≤20 intravenous infusions followed by 1200 mg/d orally) or placebo for 6 months...
May 2017: Stroke; a Journal of Cerebral Circulation
https://read.qxmd.com/read/27692173/highly-purified-calf-hemodialysate-actovegin%C3%A2-may-improve-endothelial-function-by-activation-of-proteasomes-a-hypothesis-explaining-the-possible-mechanisms-of-action
#37
JOURNAL ARTICLE
Andriy Stelmakh, Orest Abrahamovych, Andriy Cherkas
Highly purified calf hemodialysate (HPCH) known as Actovegin® or Solcoseryl® is one of the most controversial drugs currently marketed worldwide. It is not registered as drug in some countries and therefore its medical use there is illegal, while in others it is often among the top 10 of the best-selling medications. It could be also found in the list of the "most useless drugs" and was banned for short time by World Anti-Doping Agency as performance enhancer. However, the degree of its usefulness or uselessness remains unclear and there is not enough convincing data to make reliable conclusions...
October 2016: Medical Hypotheses
https://read.qxmd.com/read/27500876/-an-experimental-in-vitro-study-of-antioxidant-and-antiradical-properties-of-cytoflavin-vinpocetine-actovegin-and-ethylmethylhydroxypyridine-succinate
#38
JOURNAL ARTICLE
Trofimova S A, Dubinina E E, Balunov O A, Leonova N V
AIM: To investigate experimentally in vitro the antioxidant and anti-radical activity of several drugs. MATERIAL AND METHODS: Antioxidant activity was assessed by induced luminol-dependent chemiluminescence (CL). An impact on the generation of reactive oxygen species (O2-, OH, 1D, H2O2, HClO) and their ability to inhibit the auto-oxidation of quercetin combined with the generation of superoxide radical anion were determined. Anti-radical activity was studied by the method of restoring a stable radical α-α-diphenyl-β-picryl hydrazine (DPPH) molecule of the alleged anti-oxidant...
2016: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/27029445/-the-efficacy-of-pharmacological-preconditioning-in-carotid-endarterectomy
#39
JOURNAL ARTICLE
M P Kuznetsov, A I Fedin, A V Karalkin, K B Frolov, N V Kunitsin, S M Yumin, E A Kholopova, A V Knyazev
OBJECTIVE: To assess the efficacy of pharmacological preconditioning with actovegin in carotid endarterectomy. MATERIAL AND METHODS: The study was based on the results of surgical treatment of 80 patients with hemodynamically significant uni- and bilateral lesions of carotid arteries. Half of the patients was operated immediately and others after pharmacological preconditioning with actovegin in dose of 1200 mg/daily during 1,5 months. RESULTS: Pharmacological preconditioning with actovegin increased the cerebral perfusion determined with one-photon emission computed tomography that improved significantly results of the surgery...
2016: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/26978048/-immune-and-oxygen-disturbances-in-patients-with-chronic-cerebral-ischemia-and-their-correction
#40
JOURNAL ARTICLE
A I Konoplya, V B Laskov, A A Shul'ginova
OBJECTIVE: To determine the dynamics of immunometabolic characteristics in patients with chronic ischemia of the brain (discirculatory encephalopathy - DE) under the influence of various combinations of neuroprotective and antioxidant drugs and on this basis to identify the most effective therapeutic combinations. MATERIAL AND METHODS: Authors analyzed the results of treatment of 57 patients with DE, stage II, comorbid to hypertension, stage II, which were divided into 3 groups that received comprehensive basic and advanced therapy with paired combinations of neuroprotective and antioxidant drugs...
2015: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
keyword
keyword
166809
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.